Lindner Center of HOPE congratulates Tracy Suzanne Cummings, MD, as a 2023 Cincy Best Doc in the Child & Adolescent Psychiatry category.
This is the premier medical award for all practitioners in the Greater Cincinnati region. Nominations were open to the community and allowed for nominations across many different categories, and the best in each category were chosen. Being named as a Cincy Best Docs physician is an exceptional honor.
Heather Melena, APRN, PMHNP-BC,
Psychiatric Nurse Practitioner, Lindner Center of HOPE
Living with a chronic illness can be difficult to manage not only physically but also emotionally and mentally as well. The challenges that can come with chronic illness include learning to cope with the symptoms of that diagnosis, figuring out ways to alleviate your symptoms, doctor’s appointments and strain to financial responsibilities and interpersonal relationships. On top of trying to figure out new ways to handle everything that comes with chronic illness, the emotional and mental strain can feel overwhelming and paralyzing. Psychological distress has been shown to increase with chronic disease and its accompanying treatment protocols as well as the many other areas affected in one’s life. It has also been well documented that continued stress and/or distress can lead to poor health outcomes and mental illness (Sheth et al, 2023). Thus, finding ways to find acceptance, cope with the feelings of powerlessness, and learning to live within the limitations caused by one’s chronic illness is imperative to finding relief from the mental and emotional turmoil brought on by physiological changes of illness.
Seeking help from a mental health provider (with or without the use of medications), engaging in individual and group therapy, attending support groups are all ways to tackle the mental and emotional aspects of chronic illness. Studies have shown that engaging in acceptance and commitment therapy as well as learning mindfulness techniques can reduce pain intensity, depression, and anxiety with increased self-management and physical wellbeing for those living with chronic health conditions (Wallace-Boyd et al, 2023). Learning strategies such as active coping skills, planning, positive reframing, and emotional support will all be of value to learning to live with the changes experienced by persistent illness. In practice, discussion is had about learning how to live within these new limitations, being patient and kind to oneself, setting realistic expectations, and acknowledging that the way you feel physically may change from day to day- which can be extremely beneficial for someone experiencing chronic illness. Powerlessness is a tough emotional and mental barrier when struggling day to day, where much uncertainty feels uncomfortable. By practicing acceptance and self-love, we can learn to live in the present and move away from dwelling on what our bodies were once capable of or fearing what the future may hold.
The American Psychological Association (2023) defines self-efficacy as an individual’s belief in his or her capacity to engage in behaviors to achieve personal goals. This is reflected in the confidence one has to exert control over their own motivation, behavior, and social environment. Studies have shown that greater self-efficacy can increase one’s control (or belief of) over health outcomes (Sheth et al, 2023). By learning more positive coping mechanisms and increasing self-efficacy, one can gain confidence in their ability to self-manage their illness and improve their quality of life.
While it may be a difficult task, especially for those that struggle with chronic health problems, engaging in physical activity three to five days a week can be extremely beneficial. There has been endless research on the benefits of physical activity including higher quality of life, lower mortality, reduction of pain, and improved mental health. It has been shown that physical activity can positively impact the overall relationship between inflammation and mental health symptoms, thus reducing inflammation will likely improve depression and anxiety symptoms (Sheth et al, 2023). Physical activity can also improve energy, mental clarity, cognitive ability, and reduce stress and anxiety. It has been shown to improve mood, sleep, and circulation (Sheth et al, 2023).. With that being said, be patient with yourself and listen to your body- if physical activity isn’t what your body needs- rest or try low-intensity activities such as yoga or swimming.
Self-care is something we hear about all the time now- but what does that look like in practice? Self-care is the action or behaviors we incorporate into our daily lives that help not only our physical health but overall mental wellness. Incorporating self-care into our daily lives will not only improve our mood, reduce the toll stress can have on our bodies (ie inflammation, fatigue, sadness), but improve our outlook on the constantly changing physical symptoms of chronic illness. Self-care should be personalized to your needs. In practice we often discuss what someone’s “life worth living” looks like and how to achieve this. Incorporating daily self-care is a step towards learning to live within the new limitation set by illness and reframing our thought processes to think more positively which will enable us to continue moving forward despite our body’s shortcomings. Self-care includes:
(Mended Hearts, 2023)
References
American Psychological Association (2023). Teaching tip sheet: Self-efficacy. https://www.apa.org/pi/aids/resources/education/self-efficacy
Ciotti, S. (2023). “I Get It, I’m Sick Too”: An Autoethnographic Study of One Researcher/Practitioner/Patient With Chronic Illness. Qualitative Health Research, 33(14), 1305–1321. https://doi-org.northernkentuckyuniversity.idm.oclc.org/10.1177/10497323231201027
MedlinePlus (2022). Living with a chronic illness- dealing with feelings. National Library of Medicine. https://medlineplus.gov/copingwithchronicillness.html
MendedHearts(2023). Chronic illness and mental health blog. https://mendedhearts.org/chronic-illness-and-mental-health-9-tips-for-self-care/
Sheth, M. S., Castle, D. J., Wang, W., Lee, A., Jenkins, Z. M., & Hawke, L. D. (2023). Changes to coping and its relationship to improved wellbeing in the optimal health program for chronic disease. SSM Mental Health, 3. https://doi-org.northernkentuckyuniversity.idm.oclc.org/10.1016/j.ssmmh.2023.100190
Wallace-Boyd, K., Boggiss, A. L., Ellett, S., Booth, R., Slykerman, R., & Serlachius, A. S. (2023). ACT2COPE: A pilot randomised trial of a brief online acceptance and commitment therapy intervention for people living with chronic health conditions during the COVID-19 pandemic. Cogent Psychology, 10(1). https://doi-org.northernkentuckyuniversity.idm.oclc.org/10.1080/23311908.2023.2208916
The Harold C. Schott Foundation Eating Disorders Program at Lindner Center of HOPE to Host Free Webinar in Honor of National Eating Disorders Awareness Week National Eating Disorders Awareness Week is February 28, 2024 – March 5, 2024
Compassion for Ourselves: Addressing weight stigma and body shame during the journey to recovery.
Recovering from eating disorders often requires many different parts including therapy, work with a dietitian, groups, and a recovery community. A piece that often does not get addressed is the experience and trauma of weight stigma and shame around body size and weight. This talk will look at the history and internalization of both, the role they play for those with eating disorders and the necessary self-compassion and care required for recovery.
Guest presenter, Chevese Turner’s dedication to health equity began early in her career when she was part of a team working to ensure cancer patients had ongoing access to critical treatments. Driven by her own struggles and recovery, she founded the Binge Eating Disorder Association (BEDA) in 2008 to address the unmet needs of people with the most prevalent eating disorder and was integral to Binge Eating Disorder (BED) receiving its designation in the Diagnostic & Statistics Manual.
Currently, Chevese is an eating disorder and anti-weight discrimination advocate, educator and speaker, and the founder of the Body Equity Alliance in which she assists organizations and brands creating inclusive campaigns, policies and environments that feature and accommodate higher weight people. She is also a lived experience coach and a co-founder of Attune, an educational and coaching organization serving larger bodied individuals, with and without eating disorders, who want to put an end to diet dependency and weight cycling, and are seeking help navigating the healthcare system which is often biased and discriminatory toward larger bodied individuals.
Where?
This event will be run virtually through Zoom (details sent with RSVP email confirmation).
When?
Thursday, February 29, 2024
at 6:00PM EST.
Presented by the Harold C. Schott Eating Disorders Program.
RSVP at https://lindnercenter.ejoinme.org/compassion-for-ourselves
by Friday, February 22, 2024
Any questions, contact Pricila Gran at 513-536-0318 or [email protected].
FOUR 1HR CME/CEU CONTINUING EDUCATION CONFERENCE
A Four-Part Series To Discuss Strategies to Stabilize and Improve Lingering Challenges of Chronic/Sub-Acute Mental Illness and Substance Use
Brought to you by Williams House at Lindner Center of HOPE.
Join Lindner Center of HOPE residential team members as they offer four 1-hour presentations for a free CEU for each presentation attended.
Four consecutive Tuesdays at Noon ET.
Virtual Webcast Event
Target Audience:
Healthcare and Mental Health Professionals
PRESENTERS AND TOPICS OF DISCUSSION
January 30, 2024
The Clinical Benefits of an Extended Stabilization Evaluation
Post presentation the audience will be able to:
1. Outline the clinical benefits of an extended stabilization evaluation in residential treatment.
2. Identify patients who will benefit from an extended stabilization evaluation in residential care.
3. Identify the elements of an extended stabilization evaluation.
Presenters: Michael Groat, PhD, Chief Clinical Officer and Dr. William Hartmann, MD, FAPA, Medical Director of Williams House
Click here to register (RSVP by Friday, Jan. 26th, 2024)
February 6, 2024
Concurrent Treatment of Schizophrenia and Mood Disorders
Post presentation the audience will be able to:
1. Describe symptom profile, evaluation and assessment processes, and basis of how people admit to Lindner Center of HOPE’s Williams House.
2. Describe Williams House services and how to identify treatment goals and tailor your approach to each individual.
3. Describe course of care, next steps, and discharge planning.
Presenters: Megan Morrison, CNP, PMHNP-BC , Psychiatric Nurse Practitioner,, and Shelby Naghshineh, Residential Behavioral Health Care Coordinator
Click here to register (RSVP by Friday, Feb. 2nd, 2024)
February 13, 2024
Schizo-Obsessive Disorder: Differential Diagnosis and Identifying Treatment Targets
Post presentation the audience will be able to:
1. Describe what stabilization and evaluation look like for an individual with obsessive-compulsive symptoms and concerns for psychosis.
2.Describe the evaluation process and diagnostic questions that are answered for these patients.
3.Describe the evaluation process, conceptualization, and treatment recommendations for a patient who presents with this disorder.
Presenters: Lindsey Collins Conover, PhD, Staff Psychologist, and Margot Brandi, MD, Medical Director of Sibcy House
Click here to register (RSVP by Friday, Feb. 9th, 2024)
February 20, 2024
Making the ‘Case’ for Stabilizing Evaluation and Restorative Treatment: Three Case Studies
Post presentation the audience will be able to:
1. Differentiate between inpatient care and stabilizing evaluation.
2. Recognize the benefits of integrated and interdisciplinary treatment with a seamless transition into further mental health services.
3. Identify a variety of specialized treatments offered within stabilizing evaluation.
Presenters: Michael Hill, Residential Behavioral Health Care Coordinator and Adan Liendo, LPCC-S, Residential Counselor
Click here to register (RSVP by Friday, Feb. 16th, 2024)
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Lindner Center of HOPE. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity. Each activity has been approved for 1.0 AMA PRA Category 1 Credit™.
The Ohio Psychological Association under approval number P099-311067501 (2010-2012) approves the University of Cincinnati College of Medicine
Department of Psychiatry for 4 mandatory continuing education credits for Ohio Licensed Psychologists.
DISCLAIMER
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
For questions Contact: Pricila Gran at 513-536-0318 or [email protected]
Super Bowl Event, Feb. 11, 2024
Event Date: 02/11/24
Touchdown for HOPE is a classy and fun Super Bowl party with big screen televisions, plush seating, and signature Cincinnati food favorites and other upscale tailgate-style treats. All taking place in a sports fan’s dream location –overlooking the baseball field. Tickets are $100 per guest, but a young professional’s ticket, for those 35 and under, is priced at $75. Reservations include free parking in Central Riverfront Garage and Cincinnati favorites such as LaRosa’s pizza, Skyline Chili, Montgomery Inn ribs and UDF ice cream food and much more.
Proceeds from this year’s event supports the Center’s Transforming HOPE Capital Campaign. Funding enables the Center to add treatment units, expand wellness facilities, and guarantee the recruitment and retention of high-quality clinicians.
WHEN: Thursday, January 18, 2024
9am-11am and 3pm-5pm (Bring your resume)
WHERE: Lindner Center of HOPE – gymnasium
4075 Old Western Row Road
Mason, OH 45040
We are currently hiring various positions. Check our website for openings:
Visit our website to view more information on these positions:
https://lindnercenterofhope.org/careers/or contact HR at [email protected]
By Danielle Beltz, MSN, PMHNP-BC, Psychiatric Nurse Practitioner, Lindner Center of HOPE
Pregnancy and childbirth can be one of the most rewarding and fulfilling things a woman can do in her
lifetime but can hand in hand be one of most challenging and emotionally taxing times.
A female goes through not only physical changes throughout pregnancy but also hormonal, emotional,
and psychological changes. In addition, a pregnancy can bring stress and emotional hardship to their
interpersonal dynamics.
A lot of new moms experience postpartum “baby blues” after giving birth which differentiates from
postpartum depression. Symptoms usually include sadness, irritability, moodiness, crying spells, and
decreased concentration. Baby blues usually begin within 2 to 35 days after childbirth and can persist up
to 2 weeks. When these symptoms last longer than 2 weeks this is when the mother should consider talking
to a healthcare provider.
About one in seven women develop postpartum depression. It most commonly occurs 6 weeks after delivery but can begin prior to
delivery as well. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) a major depressive episode with the onset
of pregnancy or within 4 weeks of delivery is considered postpartum depression. Five of the nine symptoms must be present nearly every
day for at least two weeks and constitute a change from previous functioning to be diagnosed. Depression or loss of interest in addition
to the following symptoms must be present:
• Depressed mood (subjective or observed) most of the day
• Diminished interest or pleasure in all or most activities
• Insomnia or hypersomnia
• Psychomotor agitation or retardation
• Feelings of worthlessness or guilt
• Loss of energy or fatigue
• Recurrent suicidal ideation, thoughts of death or attempts
• Diminished concentration or indecisiveness
• Change in weight or appetite (5% weight change over 1 month)
Fifty percent of postpartum major depressive episodes begin before
delivery so collectively these episodes are described as peripartum
episodes. Mothers with peripartum major depressive episodes commonly have severe anxiety and panic attacks.
The exact etiology of postpartum depression is unknown. Several factors have been reported to contribute to the development of
postpartum depression. The physical and hormonal fluctuations resulting from pregnancy influence postpartum women to develop
depression when stressful and emotional events coincide with childbirth. Some of these factors include the stress of motherhood, difficult
labor, poor financial and family support, and harmful health outcomes of childbirth. Lower socioeconomic demographic, personal or
family history of depression, anxiety, or postpartum depression, PMDD, complications in pregnancy and birth, and mothers who have
gone through infertility treatments have also all been suggested to be strong contributors.
Postpartum depression not only affects the mother’s health but also the relationship the mother has with her infant and that child’s
development. Studies have shown that children are at a greater probability of developing behavioral, cognitive, and interpersonal problems
whose mothers have postpartum depression. It can also lead to inability to breastfeed and marital conflict.
Postpartum psychosis is another severe kind of depression but is not the same thing as postpartum depression. Around 1 in 500 or 1 in
1,000 women has postpartum psychosis after delivering a baby. It commonly starts the first 2 weeks after giving birth. Women who are
also diagnosed with bipolar disorder or schizoaffective disorder are more prone to have postpartum psychosis than women who are not
diagnosed with other mental health conditions.
Postpartum psychosis is considered a psychiatric emergency with a capacity of suicide and infanticidal threat. Some symptoms include
delusions, hallucinations, unusual behavior, paranoia, and sleep disturbances. If postpartum psychosis is suspected help should be sought
immediately.
Psychotherapy and antidepressant medications are the first line treatments for postpartum depression. Psychotherapy is considered first
line for women with mild to moderate depression or if they have concerns of starting a medication while breastfeeding. For moderate to
severe depression therapy and antidepressant medications are recommended. The most common medication for postpartum depression is
an SSRI or selective serotonin reuptake inhibitor. Once an efficacious dose is reached, treatment should persist for 6-12 months to prevent
relapse of symptoms. Risk versus benefits of treated versus untreated depression while breastfeeding or pregnant should be discussed.
Transcranial Magnetic Stimulation (TMS) is an alternate therapy that can be used for women who have concerns about their child being
exposed to a medication. Although, the risk of taking an SSRI while breastfeeding is relatively low. ECT is another option for women with
severe postpartum depression who do not respond to traditional treatment. It can be particularly helpful with psychotic depression.
Zurzuvae (zuranolone) is the first oral medication approved by the FDA specifically for the treatment of postpartum depression in adults.
Until August 2023, treatment for PPD was only available as an IV (Brexanolone) and was only available at certified healthcare facilities.
People with depression especially new mothers and postpartum mothers may not identify or accept that they’re depressed. They also
may be unaware of the signs and symptoms of depression. If you are questioning whether a friend or family member has postpartum
depression or is developing signs of postpartum psychosis, assist them in pursuing medical treatment and recognize that help is accessible.
References:
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
Commissioner, O. of the. (n.d.). FDA approves first oral treatment for postpartum depression. U.S. Food and Drug Administration. https://www.fda.
gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression#:~:text=Today%2C%20the%20U.S.%20Food%20
and,the%20later%20stages%20of%20pregnancy
Guo, L. , Zhang, J. , Mu, L. & Ye, Z. (2020). Preventing Postpartum Depression With Mindful Self-Compassion Intervention. The Journal of Nervous and
Mental Disease, 208 (2), 101-107. doi: 10.1097/NMD.0000000000001096.
Mayo Foundation for Medical Education and Research. (2023, April 14). “I’m happy to be a new mom. but why am I feeling
so sad?” Mayo Clinic. https://mcpress.mayoclinic.org/mental-health/im-happy-to-be-a-new-mom-but-why-am-i-feeling-sosad/?
mc_id=global&utm_source=webpage&utm_medium=l&utm_content=epsmentalhealth&utm_
campaign=mayoclinic&geo=global&placementsite=enterprise&invsrc=other&cauid=177193
Miller, L. J. (2002). Postpartum depression. JAMA : The Journal of the American Medical Association, 287(6), 762-765. https://doi.org/10.1001/jama.287.6.762
Mughal S, Azhar Y, Siddiqui W. Postpartum Depression. [Updated 2022 Oct 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023
Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519070/
Postpartum depression. March of Dimes. (n.d.). https://www.marchofdimes.org/find-support/topics/postpartum/postpartum-depression?gad_
source=1&gclid=EAIaIQobChMIqKLemfTfggMVq0VyCh3ouwGDEAAYBCAAEgKxjPD_BwE
Silverman, M. E., Reichenberg, A., Savitz, D. A., Cnattingius, S., Lichtenstein, P., Hultman, C. M., Larsson, H., & Sandin, S. (2017). The risk factors for postpartum
depression: A population-based study. Depression and Anxiety, 34(2), 178–187. https://doi-org.uc.idm.oclc.org/10.1002/da.22597
Stewart, D. E., & Vigod, S. (2016). Postpartum depression. The New England Journal of Medicine, 375(22), 2177-2186. https://doi.org/10.1056/NEJMcp1607649
LCOH-UC study: Spinal cord stimulation a potential new way to treat depression
Lindner Center of HOPE, UC researcher publishes pilot study showing feasibility of method
A pilot clinical trial led by Lindner Center of HOPE Research Institute and University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible, well-tolerated, and shows therapeutic potential to treat depression.
The results of the trial were published in the journal Molecular Psychiatry on Dec. 20. View link at https://rdcu.be/dt41x
Research background
Principal investigator Francisco Romo-Nava, MD, PhD, said his research focuses on how brain-body communication is involved in psychiatric disorders.
“We think that the connection between the brain and the body is essential for psychiatric disorders,” said Romo-Nava, Associate Chief Research Officer for the Research Institute at the Lindner Center of HOPE, Associate Professor in the Department of Psychiatry and Behavioral Neurosciences at UC, and a UC Health physician scientist. “Many of the symptoms of mood disorders or eating disorders or anxiety disorders have to do with what one could interpret as dysregulation in this brain-body interaction.”
Romo-Nava said pathways of neurons located in the spinal cord convey information from the body to regions of the brain that are involved in the emotional experience we know as mood. When functioning properly, the brain uses this information to constantly make adjustments to help regulate a person’s mood.
While major depressive disorder can have many different causes, one contributor could be this pathway being overloaded with information.
“For example, chronic stress could lead to a hyperactive brain-body circuit that eventually burns the system out and prevents it from adjusting itself in an effective and optimal way,” Romo-Nava said.
The research team looked at different ways to modulate this interaction between the brain and body and developed a novel approach through non-invasive spinal cord stimulation. Romo-Nava received a patent for the device obtained a patent in 2020 for the stimulation method used after working with UC’s Office of Innovation.
The spinal cord stimulation is designed to decrease the flow of information in the brain-body circuit so that the brain is better able to readjust and regulate itself.
“Spinal cord stimulation is thought to help the brain modulate itself as it should by decreasing the noise or decreasing the hyperactive signaling that may be in place during a depressive syndrome,” Romo-Nava said.
The investigational device that was used is no larger than a shoe box, with the active electrode placed on the patient’s back and the return electrode placed on their right shoulder.
Trial details
With funding through a Brain & Behavior Research Foundation NARSAD Young Investigator Award, Romo-Nava designed the pilot study to test the feasibility and tolerability of spinal cord stimulation for patients with major depressive disorder.
A total of 20 patients were enrolled in the trial, with half randomized to receive the active version of the spinal cord stimulation and half receiving a different version of current that was not expected to have much of an effect.
Patients went to the Lindner Center of HOPE for three 20-minute sessions a week for eight weeks, for a total of 24 spinal stimulation sessions.
Trial results
Romo-Nava said like with most pilot studies, the primary focus of the study was the feasibility and safety of the intervention and how well patients tolerated the stimulation. The study was designed so that the dose of stimulation could be decreased if needed, but Romo-Nava said all patients tolerated the initially prescribed dose well.
“We used a current that is so small that it’s about 10 times smaller than the one known to induce tissue damage, so that’s also pretty encouraging because there’s a lot to explore in terms of what is the optimal dose and session frequency,” he said.
Side effects of the treatment were mild, including skin redness at the site of stimulation and brief non-painful itching or burning sensations that only lasted during the treatment sessions. The skin redness typically did not last more than 20 minutes after a session, Romo-Nava said.
A virtual reconstruction of how the current from the device moves through the body showed the current reaches spinal gray matter in the spinal cord, but does not reach the brain itself.
“That supports our hypothesis that it is the modulation of these pathways of information that then may induce an effect on the mood-relevant areas in the brain,” he said. “So it is not the current that reaches the brain, it is the change in the signal that then has an effect. This study is not sufficient to prove all of these components of the hypothesis, but we think it’s a great start.”
Patients that received the active stimulation had a greater decrease in the severity of their depressive symptoms compared to the control group, but Romo-Nava cautioned the study was limited by its small sample size. These results will need to be replicated in much larger studies to be confirmed.
“We need to be cautious when we interpret these results because of the pilot nature and the small sample size of the study,” he said. “While the primary outcome was positive and it shows therapeutic potential, we should acknowledge all the limitations of the study.”
Data showed participants’ resting blood pressure did not change over the course of the eight weeks, but their diastolic blood pressure (the bottom number of a blood pressure reading) decreased for a short time after each session in a cumulative way during the study.
“That may mean that we may be actually inducing a form of plastic effect on the brain-body interaction circuit that is also involved in autonomic functions like blood pressure and heart rate,” Romo-Nava said. “This is very preliminary, but it is also another signal that is in the right direction.”
Moving forward, Romo-Nava said the research team is seeking additional funding to put together an expanded trial and develop a portable version of the spinal cord stimulation device. If further studies confirm the stimulation is safe and effective to treat psychiatric disorders, future work will also be needed to find the optimal dose, frequency and conditions it can be used for.
Lindner Center of HOPE provides excellent, patient-centered, scientifically advanced care for individuals suffering with mental illness. A state-of-the-science mental-health center and charter member of the National Network of Depression Centers, the center provides psychiatric hospitalization and partial hospitalization for adults, outpatient services for all ages, diagnostic and short-term residential services for adults, intensive outpatient program for substance abuse and co-occurring disorders for adults and research. The center is enhanced by its partnership with UC Health as its clinicians are ranked among the best providers locally, nationally and internationally. Together Lindner Center of HOPE and UC Health offer a true system of mental health care in the Greater Cincinnati area and across the country. The center is also affiliated with the University of Cincinnati (UC) College of Medicine.
##
REGISTER NOW! 1 CME/CEU OFFERED
Participants in the webcast will be able to:
Treatment Options for OCD Feb 2024 webcast flyer
Click here for the complete 2024 webcast schedule
Target Audience:
Psychiatrists, Primary Care Physicians, Non-psychiatric MDs, Nurse Practitioners, , Social Workers, Psychologists, Registered Nurses, and Mental Health Specialists and interested parties as well
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Lindner Center of HOPE. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credits
commensurate with the extent of their participation in the activity.
The Ohio Psychological Association under approval number P099-311067501 (2010-2012) approves the University of Cincinnati College of Medicine
Department of Psychiatry for 1 mandatory continuing education credit for Ohio Licensed Psychologists.
The This activity has been approved for 1 clock hour of CEU by The State of Ohio Counselor, Social Work, Marriage and Family Therapist Board.
DISCLAIMER
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
Yesterday employees were treated to a delicious holiday lunch meal along with gathering gifts for the holiday outreach.
